(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Brooge Energy Limited , Dogness, and Super Micro Computer.

The three biggest losers today are BioSig Technologies, Aspen Group, and Datasea.

Winners today

1. Brooge Energy Limited (BROGW) – 122.39%

Brooge Energy Limited, through its subsidiaries, provides oil storage and related services at the Port of Fujairah in the United Arab Emirates. It operates phase I and phase II facilities comprising 22 tanks with a capacity of approximately 1,001,388 cubic meters for offering storage, heating, and blending of fuel oil and clean petroleum products, including aviation fuel, gas oil, gasoline, marine gas oil, and naphtha. The company was formerly known as Brooge Holdings Limited and changed its name to Brooge Energy Limited in April 2020. Brooge Energy Limited was incorporated in 2019 and is headquartered in Dubai, the United Arab Emirates.

NASDAQ ended the session with Brooge Energy Limited rising 122.39% to $0.01 on Thursday while NASDAQ jumped 2.96% to $16,041.62.

More news about Brooge Energy Limited .

2. Dogness (DOGZ) – 63.83%

Dogness (International) Corporation, through its subsidiaries, designs, manufactures, and sells fashionable products for dogs and cats worldwide. The company provides pet leashes, pet collars, pet harnesses, and retractable leashes, as well as lanyards; gift suspenders, pet belt ribbons, laces, elastic belts, computer jacquard ribbons, and high-grade textile laces; mouth covers and pet charms; climbing hooks; and intelligent pet products, such as app-controlled pet feeders, pet water fountains, and smart pet toys, as well as pet shampoos. It also offers ribbon dyeing service and pet grooming services. It offers its products to wholesalers and retailers. The company was founded in 2003 and is headquartered in Dongguan, the People's Republic of China.

NASDAQ ended the session with Dogness rising 63.83% to $6.75 on Thursday, after two successive sessions in a row of losses. NASDAQ rose 2.96% to $16,041.62, after three consecutive sessions in a row of losses, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Dogness has a trailing twelve months EPS of $-3.6.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.05%.

Yearly Top and Bottom Value

Dogness’s stock is valued at $6.75 at 16:32 EST, way below its 52-week high of $23.60 and way above its 52-week low of $2.79.

Moving Average

Dogness’s worth is way above its 50-day moving average of $4.04 and way below its 200-day moving average of $9.68.

Volume

Today’s last reported volume for Dogness is 2724550 which is 2147.87% above its average volume of 121206.

More news about Dogness.

3. Super Micro Computer (SMCI) – 34.01%

Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally. Its solutions range from complete server, storage systems, modular blade servers, blades, workstations, full racks, networking devices, server sub-systems, server management software, and security software. The company provides application-optimized server solutions, rackmount and blade servers, storage, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and technical documentation, and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. The company was incorporated in 1993 and is headquartered in San Jose, California.

NASDAQ ended the session with Super Micro Computer jumping 34.01% to $983.87 on Thursday while NASDAQ jumped 2.96% to $16,041.62.

Earnings Per Share

As for profitability, Super Micro Computer has a trailing twelve months EPS of $12.77.

PE Ratio

Super Micro Computer has a trailing twelve months price to earnings ratio of 77.05. Meaning, the purchaser of the share is investing $77.05 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.92%.

Moving Average

Super Micro Computer’s worth is way above its 50-day moving average of $436.53 and way above its 200-day moving average of $300.73.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 249.7% and 101.4%, respectively.

More news about Super Micro Computer.

4. Novavax (NVAX) – 21.98%

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NASDAQ ended the session with Novavax rising 21.98% to $4.86 on Thursday while NASDAQ rose 2.96% to $16,041.62.

Earnings Per Share

As for profitability, Novavax has a trailing twelve months EPS of $-6.23.

Volatility

Novavax’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.05%, a negative 0.07%, and a positive 2.92%.

Novavax’s highest amplitude of average volatility was 2.05% (last week), 2.93% (last month), and 2.92% (last quarter).

Moving Average

Novavax’s worth is higher than its 50-day moving average of $4.61 and way under its 200-day moving average of $6.72.

More news about Novavax.

5. Corbus Pharmaceuticals Holdings (CRBP) – 16.52%

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, an endocannabinoid small molecule drug for the treatment of obesity and related metabolic diseases; and lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial or the treatment of inflammation and fibrosis. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.

NASDAQ ended the session with Corbus Pharmaceuticals Holdings jumping 16.52% to $27.15 on Thursday while NASDAQ jumped 2.96% to $16,041.62.

Earnings Per Share

As for profitability, Corbus Pharmaceuticals Holdings has a trailing twelve months EPS of $-11.12.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -224.63%.

More news about Corbus Pharmaceuticals Holdings.

6. CohBar (CWBR) – 15.79%

CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.

NASDAQ ended the session with CohBar jumping 15.79% to $0.88 on Thursday, after three sequential sessions in a row of losses. NASDAQ rose 2.96% to $16,041.62, after three consecutive sessions in a row of losses, on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, CohBar has a trailing twelve months EPS of $-4.37.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -83.97%.

Moving Average

CohBar’s worth is above its 50-day moving average of $0.80 and way below its 200-day moving average of $2.01.

More news about CohBar.

7. NVIDIA (NVDA) – 15.46%

NVIDIA Corporation provides graphics, and compute and networking solutions in the United States, Taiwan, China, and internationally. The company's Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building 3D designs and virtual worlds. Its Compute & Networking segment provides Data Center platforms and systems for AI, HPC, and accelerated computing; Mellanox networking and interconnect solutions; automotive AI Cockpit, autonomous driving development agreements, and autonomous vehicle solutions; cryptocurrency mining processors; Jetson for robotics and other embedded platforms; and NVIDIA AI Enterprise and other software. The company's products are used in gaming, professional visualization, datacenter, and automotive markets. NVIDIA Corporation sells its products to original equipment manufacturers, original device manufacturers, system builders, add-in board manufacturers, retailers/distributors, independent software vendors, Internet and cloud service providers, automotive manufacturers and tier-1 automotive suppliers, mapping companies, start-ups, and other ecosystem participants. It has a strategic collaboration with Kroger Co. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.

NASDAQ ended the session with NVIDIA rising 15.46% to $779.03 on Thursday, after four sequential sessions in a row of losses. NASDAQ rose 2.96% to $16,041.62, after three sequential sessions in a row of losses, on what was an all-around bullish trend exchanging session today.

Pre-markets bask in NVIDIA, lower jobless claimsThe stock has been wallowing down -19% since the start of the year (while everyone was piling into NVIDIA stock) and -24% year over year. , In fact, NVIDIA is now trading 5x higher than its October 2022 lows - if you are still looking for a single stat why this company is so important to Wall Street, this might be it.

Earnings Per Share

As for profitability, NVIDIA has a trailing twelve months EPS of $7.56.

PE Ratio

NVIDIA has a trailing twelve months price to earnings ratio of 103.05. Meaning, the purchaser of the share is investing $103.05 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 69.17%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

NVIDIA’s EBITDA is 91.32.

Sales Growth

NVIDIA’s sales growth is 236.8% for the ongoing quarter and 232.6% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 418.2% and 396.9%, respectively.

Yearly Top and Bottom Value

NVIDIA’s stock is valued at $779.03 at 16:32 EST, higher than its 52-week high of $746.11.

Previous days news about NVIDIA

• NVIDIA earnings: another beat delivered. According to Zacks on Wednesday, 21 February, "Investor-favorite NVIDIA (NVDA Quick QuoteNVDA – Free Report) has just unveiled Q4 and fiscal year 2024 results, undoubtedly representing the most highly-awaited release of the current earnings cycle.", "Another robust quarter from NVIDIA (NVDA Quick QuoteNVDA – Free Report) has hit the tape, with scorching-hot Data Center demand and an improving gaming industry providing meaningful tailwinds. "
• Traders get crushed as “new NVIDIA” SMCI stock oops and drops. According to FXStreet on Tuesday, 20 February, "This process started on Friday as the stock that’s supposed to be the "new" NVIDIA (NASDAQ: NVDA), Super Micro Computer (NASDAQ: SMCI), lost approximately 20% of its value in a single day. "

More news about NVIDIA.

8. Moderna (MRNA) – 15.12%

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a strategic partnership with Caris Life Sciences to advance mRNA-Based oncology therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Moderna rising 15.12% to $100.83 on Thursday while NASDAQ jumped 2.96% to $16,041.62.

Moderna (mrna) Q4 earnings and revenues beat estimatesWhile Moderna has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

Earnings Per Share

As for profitability, Moderna has a trailing twelve months EPS of $-9.23.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.04%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Moderna’s stock is considered to be overbought (>=80).

More news about Moderna.

9. AMD (AMD) – 11.33%

Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. It operates through Data Center, Client, Gaming, and Embedded segments. The company offers x86 microprocessors and graphics processing units (GPUs) as an accelerated processing unit, chipsets, data center, and professional GPUs; and embedded processors, and semi-custom system-on-chip (SoC) products, microprocessor and SoC development services and technology, data processing unites, field programmable gate arrays (FPGA), and adaptive SoC products. It provides processors under the AMD Ryzen, AMD Ryzen PRO, Ryzen Threadripper, Ryzen Threadripper PRO, AMD Athlon, AMD Athlon PRO, and AMD PRO A-Series brand names; graphics under the AMD Radeon graphics and AMD Embedded Radeon graphics; and professional graphics under the AMD Radeon Pro graphics brand name. In addition, the company offers data center graphics under the Radeon Instinct and Radeon PRO V-series brands, as well as servers under the AMD Instinct accelerators brand; server microprocessors under the AMD EPYC brands; low power solutions under the AMD Athlon, AMD Geode, AMD Ryzen, AMD EPYC, AMD R-Series, and G-Series brands; FPGA products under the Virtex-6, Virtex-7, Virtex UltraScale+, Kintex-7, Kintex UltraScale, Kintex UltraScale+, Artix-7, Artix UltraScale+, Spartan-6, and Spartan-7 brands; adaptive SOCs under the Zynq-7000, Zynq UltraScale+ MPSoC, Zynq UltraScale+ RFSoCs, Versal HBM, Versal Premium, Versal Prime, Versal AI Core, Versal AI Edge, Vitis, and Vivado brands; and compute and network acceleration board products under the Alveo brand. It serves original equipment and design manufacturers, public cloud service providers, system integrators, independent distributors, and add-in-board manufacturers through its direct sales force, and sales representatives. Advanced Micro Devices, Inc. was incorporated in 1969 and is headquartered in Santa Clara, California.

NASDAQ ended the session with AMD rising 11.33% to $182.90 on Thursday, after four sequential sessions in a row of losses. NASDAQ rose 2.96% to $16,041.62, after three consecutive sessions in a row of losses, on what was an all-around positive trend exchanging session today.

Advanced micro devices stock forecast: AMD rallies 11% in light of NVIDIA earnings reportThursday’s rally has placed AMD stock in contention with the all-time high of $184.92 from January 25 just a month ago. , One good sign for AMD is that Cantor Fitzgerald noted that demand is so strong for Nvidia’s newest AI products that there will most likely be shortages.

Earnings Per Share

As for profitability, AMD has a trailing twelve months EPS of $0.53.

PE Ratio

AMD has a trailing twelve months price to earnings ratio of 345.1. Meaning, the purchaser of the share is investing $345.1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.54%.

Yearly Top and Bottom Value

AMD’s stock is valued at $182.90 at 16:32 EST, below its 52-week high of $184.92 and way above its 52-week low of $75.92.

Moving Average

AMD’s worth is way higher than its 50-day moving average of $155.00 and way above its 200-day moving average of $121.08.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AMD’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.2%, now sitting on 22.68B for the twelve trailing months.

More news about AMD.

10. Check-Cap Ltd. (CHEK) – 11.16%

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

NASDAQ ended the session with Check-Cap Ltd. jumping 11.16% to $2.39 on Thursday, following the last session’s upward trend. NASDAQ rose 2.96% to $16,041.62, after three sequential sessions in a row of losses, on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Check-Cap Ltd. has a trailing twelve months EPS of $-3.01.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.74%.

More news about Check-Cap Ltd..

Losers Today

1. BioSig Technologies (BSGM) – -31.08%

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

NASDAQ ended the session with BioSig Technologies falling 31.08% to $0.36 on Thursday while NASDAQ rose 2.96% to $16,041.62.

Earnings Per Share

As for profitability, BioSig Technologies has a trailing twelve months EPS of $-4.7.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5977.35%.

More news about BioSig Technologies.

2. Aspen Group (ASPU) – -21.15%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group falling 21.15% to $0.21 on Thursday, after three sequential sessions in a row of gains. NASDAQ rose 2.96% to $16,041.62, after three sequential sessions in a row of losses, on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.95%.

Volatility

Aspen Group’s last week, last month’s, and last quarter’s current intraday variation average was 13.64%, 1.65%, and 4.85%.

Aspen Group’s highest amplitude of average volatility was 13.64% (last week), 4.37% (last month), and 4.85% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aspen Group’s stock is considered to be oversold (<=20).

Moving Average

Aspen Group’s worth is way higher than its 50-day moving average of $0.17 and way higher than its 200-day moving average of $0.16.

Sales Growth

Aspen Group’s sales growth is negative 24% for the present quarter and negative 29.3% for the next.

More news about Aspen Group.

3. Datasea (DTSS) – -16.98%

Datasea Inc., through its subsidiaries, provides technology and information systems in the People's Republic of China. The company provides smart city solutions and 5G messaging applications. It also offers its smart security solutions primarily to schools, tourist or scenic attractions, and public communities. In addition, the company provides intelligent acoustics products, which include ultrasonic air sterilizer, air purification and deodorization, and other products. The company was formerly known as Rose Rock, Inc. and changed its name to Datasea Inc. in October 2015. Datasea Inc. was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Datasea falling 16.98% to $6.06 on Thursday while NASDAQ jumped 2.96% to $16,041.62.

Earnings Per Share

As for profitability, Datasea has a trailing twelve months EPS of $-5.68.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1365.7%.

Volume

Today’s last reported volume for Datasea is 202499 which is 88.69% below its average volume of 1791000.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8532.7%, now sitting on 25.14M for the twelve trailing months.

More news about Datasea.

4. Fiverr (FVRR) – -14.72%

Fiverr International Ltd. operates an online marketplace worldwide. Its platform enables sellers to sell their services and buyers to buy them. The company's platform includes approximately 600 categories in ten verticals, including graphic and design, digital marketing, writing and translation, video and animation, music and audio, programming and tech, business, data, lifestyle, and photography. It also offers Fiverr Workspace, which provides freelancers a software solution to manage invoicing, contracts, time tracking, and organizing workflow; Fiverr Learn and CreativeLive that offers learning and development offerings for freelancers; ClearVoice, a subscription based content marketing solution; and Stoke Talent, a freelancer management system. In addition, the company provides back office and creative talent platforms. Its buyers include businesses of various sizes, as well as sellers comprise a group of freelancers and small businesses. The company was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

NYSE ended the session with Fiverr dropping 14.72% to $22.08 on Thursday, after five consecutive sessions in a row of losses. NYSE jumped 1.05% to $17,565.13, following the last session’s upward trend on what was an all-around up trend exchanging session today.

Fiverr international (fvrr) tops Q4 earnings estimatesWhile Fiverr has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

Fiverr (fvrr) Q4 earnings: how key metrics compare to wall street estimatesHere is how Fiverr performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Earnings Per Share

As for profitability, Fiverr has a trailing twelve months EPS of $-0.06.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.82%.

Volatility

Fiverr’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.39%, a negative 0.21%, and a positive 3.03%.

Fiverr’s highest amplitude of average volatility was 5.39% (last week), 3.87% (last month), and 3.03% (last quarter).

Previous days news about Fiverr

• Fiverr (fvrr) to post Q4 earnings: what's in the offing?. According to Zacks on Wednesday, 21 February, "An expanding partner base on Fiverr Certified is anticipated to have been positive.", "Growing momentum in Fiverr Neo is expected to have aided the company’s presence in the freelancing market."

More news about Fiverr.

5. Five9 (FIVN) – -12.72%

Five9, Inc., together with its subsidiaries, provides intelligent cloud software for contact centers in the United States and internationally. The company offers virtual contact center cloud platform that delivers a suite of applications, which enables the breadth of contact center-related customer service, sales, and marketing functions. Its platform allows to manage and optimize customer interactions across voice, chat, email, web, social media, and mobile channels directly or through its application programming interfaces. The company serves customers in various industries, such as banking and financial services, business process outsourcers, retail, healthcare, technology, and education. Five9, Inc. was incorporated in 2001 and is headquartered in San Ramon, California.

NASDAQ ended the session with Five9 sliding 12.72% to $62.01 on Thursday, after four consecutive sessions in a row of losses. NASDAQ rose 2.96% to $16,041.62, after three sequential sessions in a row of losses, on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, Five9 has a trailing twelve months EPS of $-1.16.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.76%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16%, now sitting on 879.77M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Five9’s stock is considered to be overbought (>=80).

Moving Average

Five9’s worth is way below its 50-day moving average of $77.46 and way under its 200-day moving average of $71.72.

Previous days news about Five9

• Five9 (fivn) Q4 earnings and revenues surpass estimates. According to Zacks on Wednesday, 21 February, "While Five9 has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about Five9.

6. TrueBlue (TBI) – -11.34%

TrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company's PeopleReady segment provides general, industrial, and skilled trade staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries. Its PeopleManagement segment offers contingent, on-site industrial staffing, and commercial driver services, which includes on-site management and recruitment for the contingent industrial workforce of manufacturing, warehousing, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The company's PeopleScout segment provides recruitment process outsourcing, talent advisory services, and managed service provider solutions including sourcing, screening, hiring, and onboarding services; operates Affinix, a technology platform which uses artificial intelligence and machine learning for real-time insights; and contingent labor programs including vendor selection, performance management, compliance monitoring, and risk management. TrueBlue, Inc. was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. The company was incorporated in 1985 and is headquartered in Tacoma, Washington.

NYSE ended the session with TrueBlue falling 11.34% to $11.02 on Thursday, following the last session’s downward trend. NYSE jumped 1.05% to $17,565.13, following the last session’s upward trend on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, TrueBlue has a trailing twelve months EPS of $-0.16.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.97%.

More news about TrueBlue.

7. BioXcel Therapeutics (BTAI) – -10.26%

BioXcel Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI, a sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the acute treatment of agitation in Alzheimer's disease patients, and for adjunctive treatment of patients with major depressive disorder, as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition, it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701, an investigational, orally administered, systemic innate immunity activator for the treatment of rare forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.

NASDAQ ended the session with BioXcel Therapeutics sliding 10.26% to $3.15 on Thursday while NASDAQ rose 2.96% to $16,041.62.

Earnings Per Share

As for profitability, BioXcel Therapeutics has a trailing twelve months EPS of $-7.36.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -489.95%.

Sales Growth

BioXcel Therapeutics’s sales growth is 210.9% for the current quarter and 167% for the next.

More news about BioXcel Therapeutics.

8. Casa Systems (CASA) – -10.03%

Casa Systems, Inc., a communications technology company, provides solutions for next-generation physical, virtualized, and cloud native architectures for cable broadband, fixed-line broadband, and wireless networks in North America, Latin America, the Asia-Pacific, Europe, the Middle East, and Africa. It offers converged cable access platforms; wireless network core products, such as virtual evolved packet and 5G core products, as well as small cell solutions, axyom element management system, and fixed wireless access devices; and virtual, centralized, and distributed deployment, and bandwidth capacity expansion systems. The company provides optical access solutions, virtualized broadband network gateway router and multiservice router, fiber extension, and residential broadband gateways; and machine-to-machine and industrial internet of things routers. Casa Systems, Inc. was incorporated in 2003 and is headquartered in Andover, Massachusetts.

NASDAQ ended the session with Casa Systems sliding 10.03% to $0.28 on Thursday while NASDAQ jumped 2.96% to $16,041.62.

Earnings Per Share

As for profitability, Casa Systems has a trailing twelve months EPS of $-1.09.

Yearly Top and Bottom Value

Casa Systems’s stock is valued at $0.28 at 16:32 EST, way under its 52-week high of $3.85 and way above its 52-week low of $0.24.

Volume

Today’s last reported volume for Casa Systems is 608704 which is 125.42% above its average volume of 270025.

More news about Casa Systems.

9. NeuroMetrix (NURO) – -9.75%

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

NASDAQ ended the session with NeuroMetrix dropping 9.75% to $2.87 on Thursday while NASDAQ rose 2.96% to $16,041.62.

Earnings Per Share

As for profitability, NeuroMetrix has a trailing twelve months EPS of $-5.6.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.61%.

Volume

Today’s last reported volume for NeuroMetrix is 209996 which is 265.04% above its average volume of 57526.

More news about NeuroMetrix.

10. Etsy (ETSY) – -8.14%

Etsy, Inc., together with its subsidiaries, operates two-sided online marketplaces that connect buyers and sellers in the United States, the United Kingdom, Germany, Canada, Australia, France, and India. Its primary marketplace is Etsy.com that connects artisans and entrepreneurs with various consumers. The company also offers Reverb, a musical instrument marketplace; Depop, a fashion resale marketplace; and Elo7, a Brazil-based marketplace for handmade and unique items. In addition, it offers various seller services, including Etsy Payments, a payment processing service; Etsy Ads, an advertising platform; and Shipping Labels, which allows sellers in the United States, Canada, the United Kingdom, Australia, and India to purchase discounted shipping labels. Further, the company provides various seller tools, including Shop Manager dashboard, a centralized hub for Etsy sellers includes ability to manage inventory, check order status, receive notifications about repeat customers, add photos, listing videos, and purchase and print shipping labels. Additionally, it offers educational resources comprising blog posts, video tutorials, Etsy Seller Handbook, Etsy.com online forums, and insights; Etsy Teams, a platform to build personal relationships with other Etsy sellers; and a Star Seller program. As of December 31, 2022, it connected a total of 7.5 million active sellers to 95.1 million active buyers. The company was formerly known as Indieco, Inc changed its name to Etsy, Inc. in June 2006. Etsy, Inc. was founded in 2005 and is headquartered in Brooklyn, New York.

NASDAQ ended the session with Etsy dropping 8.14% to $70.85 on Thursday, following the last session’s upward trend. NASDAQ rose 2.96% to $16,041.62, after three successive sessions in a row of losses, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Etsy has a trailing twelve months EPS of $2.47.

PE Ratio

Etsy has a trailing twelve months price to earnings ratio of 28.68. Meaning, the purchaser of the share is investing $28.68 for every dollar of annual earnings.

Volume

Today’s last reported volume for Etsy is 8530150 which is 95.19% above its average volume of 4369960.

Previous days news about Etsy

• Etsy (etsy) Q4 earnings match estimates. According to Zacks on Wednesday, 21 February, "While Etsy has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about Etsy.

Stay up to date with our winners and losers daily report